Holen Sie sich die Stockscreener-App
0.9729
2.71%
-0.0271
Finanzdaten der Fate Therapeutics Inc-Aktie (FATE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
17.07%
1.907
|
1.629 | 1.86 | 3.074 | 6.772 |
Operating Expenses
|
9.40%
38.88
|
42.91 | 63.61 | 55.45 | 51.85 |
| Benefits Costs and Expenses |
100.00%
-
|
39.25 | 54.01 | - | - |
| Costs And Expenses |
0.96%
38.88
|
39.25 | 54.01 | 55.45 | 51.85 |
| Operating Income/Loss |
10.45%
-36.97
|
-41.28 | -61.75 | -52.38 | -45.08 |
| Income/Loss From Continuing Operations Before Tax |
105.07%
1.907
|
-37.62 | -52.15 | 3.074 | -38.43 |
| Income/Loss From Continuing Operations After Tax |
9.44%
-34.07
|
-37.62 | -52.15 | -47.68 | -38.43 |
|
Net Income/Loss
|
9.44%
-34.07
|
-37.62 | -52.15 | -47.68 | -38.43 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.13%
118.53
|
118.38 | 1.3797 | 117.77 | 117.47 |
| Diluted Average Shares |
0.13%
118.53
|
118.38 | 1.3797 | 117.77 | 117.47 |
| Basic Earnings Per Share |
9.38%
-0.29
|
-0.32 | -0.45 | -0.40 | -0.33 |
| Diluted Earnings Per Share |
9.38%
-0.29
|
-0.32 | -0.45 | -0.40 | -0.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):